To include your compound in the COVID-19 Resource Center, submit it here.

TLK286: Began Phase II study

Telik Inc. (TELK), South San

Read the full 59 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE